Clinical Trial Update: Bladder EpiCheck European Haematuria Study

View source ↗

Summary

Nucleix's urine-based EpiCheck test is being evaluated in a European haematuria study and is currently recruiting to assess detection of urothelial carcinomas o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma of the Renal Pelvis
• Urothelial Carcinoma of the Ureter

Drugs mentioned

• EpiCheck

Snippet

Sponsor: Nucleix Ltd. | Conditions: Hematuria, Cystoscopy | Status: RECRUITING